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ABSTRACT
Synthesis of 2-(aminoacid ester)-3-(6-methyl-2-pyridyl)-3,4-dihydro-2H-1,3,2λ5-benzoxazaphosphinin-2-thiones (3a–j) was
accomplished through a two-step process. It involves the prior preparation of 2-chloro-3-(6-methyl-2-pyridyl)-3,4-dihydro-
2H-1,3,2λ5-benzoxazaphosphinin-2-thione monochloride (2) and its subsequent reaction with the aminoacid ester hydrochlor-
ides in dry tetrahydrofuran-toluene in the presence of triethylamine at various temperatures. These compounds were character-
ized by IR, 1H, 13C, 31P NMR and mass spectral data.
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1. Introduction
Organophosphorus compounds1 continue to receive wide-
spread attention due to their ubiquity in biological systems2 and
their potential to serve as possible pharmaceuticals,3 agrochemi-
cals4 and chemical synthetic agents.5 Phosphorus derivatives
bearing an esterified aminoacid group on the phosphorus atom
have been found to display useful anti-neoplastic properties.6–9
The attachment of an aminoacid group to the phosphate moiety
is expected to increase their cellular uptake and thus enhance
their chemotherapeutic properties. In view of this we have
synthesized new 6-membered heterocycles in which aminoacid
esters are linked to the phosphorus atom. The antimicrobial
activities of these compounds were studied and are reported
below.
2. Results and Discussion
The synthesis of 2-(aminoacid ester)-3-(6-methyl-2-pyridyl)-
3,4-dihydro-2H-1,3,2λ5-benzoxazaphosphinin-2-thiones (3a–j) is
accomplished in a two-step process. The synthetic route involves
the condensation of 2-[(6-methyl-2-pyridyl)amino]methyl-
phenol (1) with thiophosphoryl chloride in dry tetrahydrofuran
in the presence of triethylamine at 40–45 °C to afford the corre-
sponding intermediate 2-chloro-3-(6-methyl-2-pyridyl)-3,4-
dihydro-2H-1,3,2λ5-benzoxazaphosphinin-2-thione (2).
In the second step the intermediate 2 was reacted with the
respective aminoacid ester hydrochlorides in dry tetrahydro-
furan-toluene in the presence of triethylamine to obtain the title
compounds 3a–j in good yields (Scheme 1). The second step of
the reaction was completed at 40–50 °C with stirring for 3–5 h.
The progress of the reaction was monitored by TLC analysis.
Aliphatic aminoacid esters (3a–e and i, j) reacted with the thione
monochloride (2) more readily than with the aromatic
aminoacid esters (3f–h). The tetrahydrofuran-toluene mixture
was found to be a good solvent system for the second step of the
reaction. The crude products obtained after removing the
solvent were purified by column chromatography on silica gel.
The synthetic and analytical data of title compounds 3a–j are
given in the experimental part.
All the compounds 3a–j exhibited absorption bands for P=S
and P-NH in the regions 805–756 cm–1 and 3402–3145 cm–1,
respectively.10 The aromatic protons of 3a–j resonated as
multiplets in the region δ 7.80–6.69 ppm. The C-4 methylene
protons gave multiplets or triplets and pairs of doublets at
δ 5.26–4.81 ppm, indicating their non-equivalence in the six-
membered chair conformation of the benzoxazaphosphinine
ring system.11 These protons couple with phosphorus and the
coupling constants differ by as much as 1 Hz. The 13C NMR spec-
tral data for 3a,c,e,f,i and j are given in the experimental part.
The endocyclic oxygen-bonded C-8a gave signals as doublets at
δ 150.7–149.9 ppm. The C-4 methylene carbon chemical shifts
appeared in the region δ 46.7–46.5 ppm. The methyl carbon,
which is linked to the pyridine ring, resonated in the region
δ 24.4–24.1 ppm. The chemical shift of the carbon atom α to the
aminoacid ester group appeared at δ 43.6–60.5 ppm. The remain-
ing carbon signals are observed in the expected regions.11 Com-
pounds 3a–j show a phosphorus-31 resonance signal in the
range of δ 58.95–62.14 ppm.11,12 The high-resolution mass spectral
data of 3a,e,i and LCMS data of 3c,f,j are provided in the experi-
mental section.
2.1. Bioactivity
Susceptibility of test organisms to the title compounds (3a–j)
was determined by employing the standard disc diffusion tech-
nique.13 All the compounds (3a–j) were tested for their antifungal
activity against the growth of Colletotrichum gloeosporioides and
Sclerotium rolfsii along with the standard fungicide carbendazim
at concentrations of 250 and 500 ppm (Table 1). Compounds 3a–j
were also screened for their antibacterial activity against the
growth of Staphylococcus aureus, Bacillus subtilis, Escherichia coli
and Klebsiella pneumoniae along with the standard gentamycin
at concentrations of 100, 200 and 300 ppm (Table 2). The test
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compounds did not posses significant antifungal or antibacterial
activity.
3. Experimental
Melting points were recorded on Buchi R-535 (Flawil, Switzer-
land) apparatus and are uncorrected. IR spectra were recorded
on a Perkin-Elmer FT-IR 240-c spectrophotometer (Waltham,
MA, USA) using KBr optics. 1H, 13C and 31P NMR spectra
were recorded on Bruker 300 or AMX 400 MHz NMR spectrome-
ters (Ettlingen, Germany) operating at 400 MHz for 1H, 100 MHz
for 13C and 161.89 MHz for 31P. NMR data were recorded in
CDCl3 and were referenced to TMS (
1H and 13C) and 85 % H3PO4
(31P). Mass spectra were recorded on a Finnigan MAT 1020/Mi-
cro-Mass Q-Tof micro AMPS MAX 10/6A, Hz 60/50 system
(Ringoes, NJ, USA) fitted with a built-in inlet system. Elemen-
tal analyses were performed using a Perkin Elmer 2400 instru-
ment at the Central Drug Research Institute (CDRI), Lucknow,
India.
3.1. Synthesis of 2-Chloro-3-(6-methyl-2-pyridyl)-3,4-
dihydro-2H-1,3,2λ5-benzoxazaphosphinin-2-thione (2)
A solution (0.002 mol) of thiophosphoryl chloride in 20 mL of
dry THF was added dropwise over a period of 20 min to a stirred
solution of 2-[(6-methyl-2-pyridyl)amino]methylphenol (1)
(0.002 mol) and triethylamine (0.004 mol) in 25 mL of THF at
0–5 °C. After stirring for 3 h at 40–45 °C, formation of the interme-
diate, 2-chloro-3-(6-methyl-2-pyridyl)-3,4-dihydro-2H-1,3,2λ5-
benzoxazaphosphinin-2-thione (2) was ascertained by TLC
analysis run in a 3:7 mixture of ethyl acetate and hexane and the
average Rf value observed was 0.75. Triethylamine hydrochlo-
ride was removed by filtration. The filtrate was used for the next
reaction step without further purification.
3.2. Typical Procedure for the Synthesis of 3a–j
To a stirred solution of aminoacid ester hydrochloride
(0.002 mol) and triethylamine (0.004 mol) in dry toluene (10 mL)
the intermediate monochloride (2), (0.002 mol) in dry tetra-
hydrofuran was added dropwise at 0 °C. After completion of the
addition, the temperature of the reaction was raised to 40–50 °C
and the reaction mixture was stirred for 3–5 h. After completion
of the reaction, as indicated by TLC conducted in 3:7 mixture
of ethyl acetate and hexane, an average Rf value of 0.60 was
observed. The reaction mixture was filtered to remove solid
triethylamine hydrochloride and the solvent was evaporated
under reduced pressure to give the crude product. It was puri-
fied by column chromatography on silica gel (100–200 mesh,
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Scheme 1
ethyl acetate:hexane, 1:9) to afford the pure compound. The
compounds thus obtained were characterized by 1H NMR, 13C




Yield 87 %; viscous liquid. δH (400 MHz, CDCl3) 7.47-7.13 (6H,
m, Ar-H), 6.81 (1H, d, J 8 Hz, Ar-H), 5.21 (1H, t, J 15.6 Hz, -CH2-),
4.90 (1H, dd, J 9.7, 14.6 Hz, -CH2-), 4.08 (1H, brs, N-H), 3.83-3.73
(2H, m, N-CH2-), 3.68 (3H, s, O-CH3) and 2.48 ppm (3H, s,
Ar-CH3); δC (100 MHz, CDCl3) 170.5 (d,
3JP-C 10 Hz, C=O), 156.8
(C-5’), 153.3 (d, 2JP-C 10 Hz, C-1’), 150.2 (d,
2JP-C 11 Hz, C-8a), 137.7
(C-3’), 129.2 (C-5), 127.0 (C-7), 126.6 (d, 3JP-C 7 Hz, C-4a), 124.6
(C-6), 118.8 (d, 3JP-C 5 Hz, C-8), 117.5 (C-4’), 110.9 (C-2’), 52.4
(O-CH3), 46.7 (-CH2-), 43.6 (N-CH2) and 24.3 ppm (Ar-CH3);
δP (CDCl3) 60.92 ppm; νmax (CHCl3) 805 (P=S), 1744 (C=O) and




Yield 83 %; viscous liquid. δH (400 MHz, CDCl3) 7.52–6.80 (7H,
m, Ar-H), 5.25 (1H, t, J 15.4 Hz, -CH2-), 4.87 (1H, dd, J 9.0, 14.8 Hz,
-CH2-), 4.14 (1H, brs, N-H), 3.80–3.71 (2H, m, N-CH2-), 4.08 (2H, q,
J 7.0 Hz, O-CH2-), 2.46 (3H, s, Ar-CH3) and 1.21 ppm (3H, t, J
7.0 Hz, O-CH2-CH3); δP (CDCl3) 60.12 ppm; νmax (CHCl3) 764
(P=S), 1742 (C=O) and 3325 cm– 1 (P-NH). Calc. for
C17H20N3O3PS: C, 54.10; H, 5.34; N, 11.13 %; found: C, 54.14; H,
5.30; N, 11.09 %.
3.3.3. Methyl 2-[3-(6-methyl-2-pyridyl)-2-thioxo-3,4-dihydro-2H-
1,3,2λ5-benzoxazaphosphinin-2-yl]aminopropanoate (3c)
Yield 76 %; viscous liquid. δH (400 MHz, CDCl3) 7.53–6.79 (7H,
m, Ar-H), 5.26–4.87 (2H, m, -CH2-), 4.16–4.07 (2H, m,
NH-CH-CO), 3.69 (3H, s, O-CH3), 2.49 (3H, s, Ar-CH3) and
1.33 ppm (3H, d, J 6.7 Hz, NH-CH-CH3); δC (100 MHz, CDCl3)
173.6 (d, 3JP-C 9 Hz, C=O), 156.8 (C-5’), 153.3 (d,
2JP-C 10 Hz, C-1’),
150.1 (d, 2JP-C 11 Hz, C-8a), 137.5 (C-3’), 129.1(C-5), 127.0 (C-7),
126.6 (d, 3JP-C 7 Hz, C-4a), 124.6 (C-6), 118.7 (d,
3JP-C 5.5 Hz, C-8),
117.4 (C-4’), 111.2 (d, 3JP-C 2 Hz, C-2’), 52.4 (O-CH3), 50.9 (d,
2JP-C
14.5 Hz, NH-CH), 46.6 (d, J 11.5 Hz, -CH2-), 24.3 (Ar-CH3) and
20.9 ppm (CH-CH3); δP (CDCl3) 61.95 ppm; νmax (CHCl3) 758
(P=S), 1741 (C=O) and 3315 (P-NH) cm–1; m/z (LCMS) 378
(M+H); calc. for C17H20N3O3PS: C, 54.10; H, 5.34; N, 11.13 %;
found: C, 54.13; H, 5.30; N, 11.17 %.
3.3.4. Methyl 3-methyl-2-[3-(6-methyl-2-pyridyl)-2-thioxo-3,4-
dihydro-2H-1,3,2λ5-benzoxazaphosphinin-2-yl]aminobutanoate (3d)
Yield 81 %; viscous liquid. δH (400 MHz, CDCl3) 7.50–6.75 (7H,
m, Ar-H), 5.20–4.89 (2H, m, -CH2-), 4.02–3.94 (1H, m,
NH-CH-CO), 3.72 (3H, s, O-CH3), 2.48 (3H, s, Ar-CH3), 1.55–1.45
(1H, m, -CH-(CH3)2) and 1.12 ppm (6H, d, J 6.8 Hz, -CH-(CH3)2);
δP (CDCl3) 58.95 ppm; νmax (CHCl3) 760 (P=S), 1740 (C=O) and
3329 cm–1 (P-NH). Calc. for C19H24N3O3PS: C, 56.29; H, 5.97;
N, 10.36 %; found: C, 56.24; H, 5.93; N, 10.30 %.
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Table 1 Antifungal activity of compounds 3a–j.
Compound Zone of inhibition/mm a
Colletotrichum gloeosporioides Sclerotium rolfsii
250 ppm 500 ppm 250 ppm 500 ppm
3a 1.8 0.5 1.0 –
3b – 0.5 0.0 –
3c 2.3 1.0 – –
3d 1.0 4.0 0.8 2.3
3e 2.8 – 5.5 1.75
3f 6.8 4.0 2.75 0.0
3g 5.3 0.0 0.0 6.8
3h 1.0 1.5 0.5 1.5
3i 3.5 0.8 0.0 4.5
3j 4.8 2.8 0.8 8.0
Carbendazim 19.0 19.5 19.0 9.25
a – indicates no activity.
Table 2 Antibacterial activity of compounds 3a–j.
Compound Zone of inhibition/mm a
Staphylococcus aureus Bacillus subtilis Escherichia coli Klebsiella pneumoniae
100 ppm 200 ppm 300 ppm 100 ppm 200 ppm 300 ppm 100 ppm 200 ppm 300 ppm 100 ppm 200 ppm 300 ppm
3a – 1.2 3.4 – – 2.0 – – – – – –
3b – – – – – 2 – – – – – 2.0
3c 4.0 6.2 7.4 2.5 3.0 5.5 2.8 4.0 5.2 – 3.4 4.0
3d 2.0 3.4 5.0 – 2.0 4.2 3.2 4.2 6.0 1.5 3.2 5.0
3e – 2.0 4.3 – 3.0 4.0 2.5 3.0 4.0 – – –
3f 9.2 12.0 14.5 8.0 11.5 15.0 10.0 12.0 15.3 8.0 13.2 16.0
3g 11.3 14.5 17.0 – 1.8 4.2 – – 2.0 – 3.2 5.3
3h 4.5 5.0 7.0 – 3.0 5.0 2.0 4.5 5.0 – 2.3 5.2
3i 8.0 11.2 13.0 – – – – – – – – –
3j 4.2 6.2 8.0 – 2.0 4.2 – – 2.0 – – 2.0
Gentamycin 19.0 19.0 20.0 18.0
a – indicates no activity.
3.3.5. Ethyl 2-[3-(6-methyl-2-pyridyl)-2-thioxo-3,4-dihydro-2H-
1,3,2λ5-benzoxazaphosphinin-2-yl]aminopentanoate (3e)
Yield 71 %; viscous liquid. δH (400 MHz, CDCl3) 7.43–7.01 (6H,
m, Ar-H), 6.74 (1H, d, J 7.2 Hz, Ar-H) 5.21–5.11 (1H, m, -CH2-),
4.92–4.81 (1H, m, -CH2-), 4.12–4.01 (3H, m, O-CH2 and NH),
3.92–3.81 (1H, m, NH-CH-CO), 2.43 (3H, s, Ar-CH3), 1.59–1.41
(2H, m, CH2-CH2-CH3), 1.16 (3H, t, J 7.8 Hz, OCH2-CH3), 1.11–1.05
(2H, m, CH2-CH2-CH3) and 0.80 ppm (3H, t, J 6.8 Hz,
CH2-CH2-CH3); δC (100 MHz, CDCl3) 172.7 (d,
3JP-C 8 Hz, C=O),
156.7 (C-5’), 153.4 (d, 2JP-C 10 Hz, C-1’), 150.1 (d,
2JP-C 11 Hz, C-8a),
137.4 (C-3’), 129.1 (C-5), 127.1 (C-7), 126.6 (d, 3JP-C 7 Hz, C-4a),
124.6 (C-6), 118.7 (d, 3JP-C 6 Hz, C-8), 117.3 (C-4’), 111.3 (d,
3JP-C 2 Hz,
C-2’), 61.3 (O-CH2), 55.2 (NH-CH-CO), 46.7 (d, J 7 Hz, -CH2-), 36.5
(d, J 5 Hz, CH2-CH2-CH3), 24.3 (Ar-CH3), 18.1 (CH2-CH2-CH3), 14.1
(O-CH2-CH3) and 13.6 ppm (CH2-CH2-CH3); δP (CDCl3)
60.43 ppm; νmax (CHCl3) 805 (P=S), 1735 (C=O) and 3310 cm
–1





Yield 87 %; solid, m.p 125–127 °C. δH (400 MHz, CDCl3) 8.00 (1H,
brs NH), 7.45–6.74 (12H, m, Ar-H), 5.19–4.87 (2H, m, -CH2-),
4.54–4.30 (1H, m, NH-CH-CO), 4.10 (1H, brs, NH), 3.23–2.98 (2H,
m, C-CH2-C), 3.54 (3H, s, O-CH3) and 2.47 ppm (3H, s, Ar-CH3);
δC (100 MHz, CDCl3) 172.3 (d,
3JP-C 8 Hz, C=O), 156.5 (C-5’), 153.0
(d, 2JP-C 10 Hz, C-1’), 149.9 (d,
2JP-C 10.5 Hz, C-8a), 137.3 (C-3’), 137.2,
135.8 (indole bridged carbons), 129.0 (C-5), 127.1 (C-7), 126.9
(CH-pyrrole), 126.6 (d, 3JP-C 7.5 Hz, C-4a), 124.5 (C-6), 123.1, 122.9,
121.8, 119.2, 118.2 (d, J 6 Hz, C-8), 117.3 (C-4’), 111.1 (C-2’), 108.9
(C-pyrrole), 55.6 (O-CH3), 52.0 (d, J 5.5 Hz, NH-CH-CO), 46.5 (d, J
6.5 Hz, -CH2), 30.0 (CH2-indole) and 24.1 ppm (Ar-CH3); δP
(CDCl3) 62.06 ppm; νmax (KBr) 756 (P=S), 1740 (C=O) and
3380 cm– 1 (P-NH); m/z (LCMS) 494 (M+H); calc. for
C25H25N4O3PS: C, 60.97; H, 5.12; N, 11.38 %; found: C, 60.93; H,




Yield 83 %; solid, m.p 75–78 °C. δH (300 MHz, CDCl3) 8.25 (1H,
brs NH), 7.80–6.73 (9H, m, Ar-H), 5.12–4.86 (3H, m, -CH2- and
NH-CH), 4.45 (1H, brs, NH), 3.61 (3H, s, O-CH3), 3.11–2.91 (2H,
m, NH-CH-CH2) and 2.45 ppm (3H, s, Ar-CH3); δP (CDCl3)
61.92 ppm; νmax (KBr) 799 (P=S), 1742 (C=O) and 3145 cm
–1
(P-NH). Calc. for C20H22N5O3PS: C, 54.17; H, 5.00; N, 15.79 %;
found: C, 54.12; H, 5.05; N, 15.75 %.
3.3.8. Methyl 2-[3-(6-methyl-2-pyridyl)-2-thioxo-3,4-dihydro-2H-
1,3,2λ5-benzoxazaphosphinin-2-yl]amino-3-phenylpropanoate (3h)
Yield 78 %; semi-solid. δH (300 MHz, CDCl3) 7.50–6.70 (12H, m,
Ar-H), 5.25–4.87 (2H, m, -CH2-), 4.25–4.18 (1H, m, NH-CH-CO),
4.10 (1H, brs, NH), 3.68 (3H, s, O-CH3), 3.11–3.02 (2H, m, CH2-Ph)
and 2.48 ppm (3H, s, Ar-CH3); δP (CDCl3) 62.14 ppm; νmax (CHCl3)
762 (P=S), 1744 (C=O) and 3328 cm–1 (P-NH). Calc. for
C23H24N3O3PS: C, 60.92; H, 5.33; N, 9.27 %; found: C, 60.88; H,
5.29; N, 9.22 %.
3.3.9. Benzyl 1-[3-(6-methyl-2-pyridyl)-2-thioxo-3,4-dihydro-2H-
1,3,2λ5-benzoxazaphosphinin-2-yl]-2-pyrrolidinecarboxylate (3i)
Yield 77 %; semi-solid. δH (400 MHz, CDCl3) 7.42–6.99 (11H, m,
Ar-H), 6.69 (1H, d, J 8 Hz, Ar-H), 5.22–4.95 (4H, m, O-CH2Ph and
-CH2-), 4.38–4.30 (1H, m, N-CH-), 3.45–3.28 (2H, m, N-CH2), 2.40
(3H, s, Ar-CH3) and 1.90–1.70 ppm (4H, m, -CH2-CH2-); δC
(100 MHz, CDCl3) 173.1 (C=O), 156.5 (C-5’), 153.3 (d,
2JP-C 10 Hz,
C-1’), 150.7 (d, 2JP-C 10 Hz, C-8a), 137.7 (C-3’), 135.6 (C-1’’), 129.1
(C-5), 128.5 (C-3’’ and C-5’’), 128.2 (C-4’’), 128.1 (C-2’’ and C-6’’),
127.1 (C-7), 126.7 (d, 3JP-C 7 Hz, C-4a), 124.5 (C-6), 118.7 (d,
3JP-C
5 Hz, C-8), 117.1 (C-4’), 110.8 ( C-2’), 66.8 (O-CH2-Ph), 60.5 (d,
2JP-C
6 Hz , N-CH-CO), 49.5 (d, 2JP-C 3 Hz, N-CH2), 46.6 (-CH2-), 31.9,
29.7 (-CH2-CH2-) and 24.4 ppm (Ar-CH3); δP (CDCl3) 59.70 ppm;
νmax (CHCl3) 803 (P=S), 1449 and 1744 cm
–1 (C=O); HRMS calc.
for C25H26N3O3PSNa: 502.1330; found: 502.1310 (M+Na).
3.3.10. Methyl 1-[3-(6-methyl-2-pyridyl)-2-thioxo-3,4-dihydro-2H-
1,3,2λ5-benzoxazaphosphinin-2-yl]-2-pyrrolidinecarboxylate (3j)
Yield 82 %; viscous liquid. δH (400 MHz, CDCl3) 7.54–6.79 (7H,
m, Ar-H), 5.23–4.88 (2H, m, -CH2-), 4.47–4.36 (1H, m, N-CH-) 3.74
(3H, s, OCH3), 3.52–3.30 (2H, m, N-CH2-), 2.49 (3H, s, Ar-CH3) and
2.05–1.68 ppm (4H, m, -CH2-CH2); δC (100 MHz, CDCl3) 173.7
(C=O), 156.5 (C-5’), 153.3 (d, 2JP-C 10.5 Hz, C-1’), 150.7 (d,
2JP-C
11 Hz, C-8a), 137.6 (C-3’), 129.1 (C-5), 127.0 (C-7), 126.6 (d, 3JP-C
7 Hz, C-4a), 124.6 (C-6), 118.6 (d, 3JP-C 10 Hz, C-8), 117.2 (C-4’),
110.9 (d, 3JP-C 2 Hz, C-2’), 60.4 (d,
2JP-C 6.5 Hz, N-CH-CO), 52.0
(OCH3), 46.6, (-CH2-), 42.2 (N-CH2), 31.9, 29.6 (-CH2-CH2-) and
24.4 ppm (Ar-CH3); δP (CDCl3) 58.96 ppm; νmax (CHCl3) 757 (P=S),
1745 (C=O) and 3402 cm–1 (P-NH); m/z (LCMS): 404 (M+H); calc.
for C19H22N3O3PS: C, 56.57; H, 5.50; N, 10.42 %; found: C, 56.62; H,
5.56; N, 10.37 %.
Acknowledgements
The authors express their thanks to Prof. C. Eswar Reddy,
Sri Venkateswara Agricultural College, Acharya N.G. Ranga
University, Tirupati, for his help in antimicrobial studies and the
Director, IISc, Bangalore, India, for providing spectral data.
References
1 (a) L.D. Quin, A Guide to Organophosphorus Chemistry, Wiley-
Interscience, New York, NY, USA, 2000; (b) R. Engel, Handbook of
Organophosphorus Chemistry, Marcel Dekker, New York, NY, USA,
1992.
2 (a) F.H. Westheimer, Science, 1987, 235, 1173–1178. (b) H. Seto and T.
Kuzuyama, Nat. Prod. Rep., 1999, 16, 589–596.
3 (a) P. Kafarski and B. Lejczak, Curr. Med. Chem., 2001, 1, 301–312; (b) O.
M. Colvin, Curr. Pharm. Des., 1999, 5, 555–560; (c) M.M. Mader and P.A.
Bartlett, Chem. Rev., 1997, 97, 1281–1301; (d) S.M. Ludeman, in From
Nerve Agent to Anticancer Drug: The Chemistry of Phosphoramide
Mustard, Biomedical Chemistry (P.F. Torrence, ed.), Wiley-Interscience,
New York, NY, USA, 2000, pp. 163–187.
4 J.E. Franz, M.K. Mao and J.A. Sikorski, Glyphosate: A Unique Global
Herbicide, American Chemical Society, Washington, DC, USA, 1997.
5 (a) B.E. Maryanoff and A.B. Reitz, Chem. Rev., 1989, 89, 863–927;
(b) T. Rein and T.M. Pedersen, Synthesis, 2002, 579–594; (c) N. Brickle-
bank, Organophosphorus Chem, 2003, 33, 289–320; (d) M.D.
McReynolds, J.M. Dougherty and P.R. Hanson, Chem. Rev., 2004, 104,
2239–2258; (e) H. Kivela, Z. Zalan, P. Tähtinen, R. Sillanpaa, F. Fulop
and K. Pihlaja, Eur. J. Org. Chem., 2005, 1189–1200 and references cited
therein.
6 C. McGuigan and P. Narashiman, Synthesis, 1993, 311–314.
7 K.G. Devine, C. McGuigan, T.J. O’Connor, S.R. Nicholis and
D. Kinchington, AIDS, 1990, 4, 371–373.
8 P.J. Cox, Biochem. Pharmacol., 1979, 28, 2045–2049.
9 M. Szekerke, Cancer Treatment Rept., 1976, 60, 347–354.
10 L.C. Thomas, Interpretation of Infrared Spectra of Organophosphorus
Compounds, Heyden & Sons, London, UK, 1974.
11 (a) P.V.G. Reddy, P. Haranath, C.S. Reddy and C.N. Raju, Indian J.
Chem., 2005, 44(B), 1437–1440; (b) Y.H. Babu, P.V.G. Reddy, C.S. Reddy,
C.D. Reddy and P.U. Devi, J. Heterocycl. Chem., 2002, 39, 1039–1044;
(c) A.U.R. Sankar, B.S. Kumar, M.V.N. Reddy, B. Haribabu and C.N.
Raju, Arkivoc, 2007, 14, 300–308; (d) T.S. Cameron, R.E. Cordes, T.
Demir and R.A. Shaw, J. Chem. Soc., Perkin Trans. 1, 1979, 2896–2901.
12 L.D. Quin and J.G. Verkade, Phosphorus-31 NMR Spectral Properties in
Compound Characterization and Structural Analysis, VCH Publishers
Inc, New York, NY, USA, 1994.
13 A.W. Bauer, W.M. Kirby, J.C. Sherris and M. Truck, Am. J. Clin. Pathol.,
1966, 45, 493–496.
RESEARCH ARTICLE M.A. Kumar, K.S. Kumar, C.D. Reddy, C.N. Raju, C.S. Reddy and P.H. Krishna, 29
S. Afr. J. Chem., 2009, 62, 26–29,
<http://journals.sabinet.co.za/sajchem/>.
